Monitor for actual sales by the listed institutional investors, as the filing itself is administrative but actual selling could create downward pressure on the stock price.
Price Chart
Executive Summary
Ovid Therapeutics has filed a shelf registration (S-3) to allow selling stockholders to resell up to 29,856,031 shares, including 19.15 million common shares and 10.7 million shares issuable upon exercise of pre-funded warrants, issued in a recent private placement. The company will not receive proceeds from this resale, but may receive nominal amounts if warrants are exercised in cash.
Key Financial Metrics
Key Facts
- Ovid Therapeutics filed S-3 shelf registration for resale of 29,856,031 shares by selling stockholders
- Shares include 19,154,321 common shares and 10,701,710 shares issuable upon warrant exercise
- Shares originated from private placement on March 19, 2026 that raised $60 million
- Company will not receive proceeds from resale but may receive nominal amounts from warrant exercises
- Registration fulfills contractual obligations to investors from private placement
Financial Impact
Up to $84.1 million in potential dilution based on $2.82 per share offering price
Risk Factors
- Potential for significant share dilution if all registered shares are sold
- Downward pressure on stock price if selling stockholders liquidate positions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-166974 |
| Document: d108102dexfilingfees.htm | 0001193125-26-166974 |
| Document: d108102dex51.htm | 0001193125-26-166974 |
| Document: d108102dex231.htm | 0001193125-26-166974 |
| Document: 0001193125-26-166974-index-headers.html | 0001193125-26-166974 |
| Document: 0001193125-26-166974-index.html | 0001193125-26-166974 |
| Document: 0001193125-26-166974.txt | 0001193125-26-166974 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 144 | $2.89 | awaiting T+60 | — | $2.15 (−25.43%) |
Jul 8, 2026 15w ago | 8-K | $2.73 $2.49 | ▼ −8.79% | ▼ −11.10% | $2.15 (−21.06%) |
Jun 3, 2026 20w ago | 8-K | $2.39 $2.93 | ▲ +22.59% | ▲ +20.10% | $2.15 (−9.83%) |
May 12, 2026 23w ago | Press Release | $2.87 $2.65 | ▼ −7.67% | ▼ −12.05% | $2.15 (−24.91%) |
Apr 27, 2026 26w ago | EFFECT | $2.69 $2.38 | ▼ −11.52% | ▼ −16.30% | $2.15 (−19.89%) |
Apr 21, 2026 26w ago | S-3 | $2.66 $2.44 | ▼ −8.27% | ▼ −13.05% | $2.15 (−18.98%) |
Apr 20, 2026 27w ago | 8-K | $2.89 $2.49 | ▼ −13.84% | ▼ −20.62% | $2.15 (−25.43%) |
Mar 18, 2026 31w ago | 8-K | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.15 (−6.30%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.15 (−6.30%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.15 (−6.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers